CME Gr Q3 2024 Adj. EPS $2.68 Beats $2.65 Estimate, Sales $1.584B Beat $1.579B Estimate
Portfolio Pulse from Benzinga Newsdesk
CME Group reported Q3 2024 earnings per share of $2.68, surpassing the analyst estimate of $2.65. The company's sales reached $1.584 billion, exceeding the expected $1.579 billion and marking an 18.42% increase from the previous year.
October 23, 2024 | 11:02 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CME Group's Q3 2024 earnings per share of $2.68 exceeded expectations, as did their sales of $1.584 billion, which represents an 18.42% increase from the previous year.
CME Group's earnings and sales both exceeded analyst expectations, which is typically a positive indicator for stock performance. The significant year-over-year sales growth further supports a positive short-term outlook for the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100